BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Koo SM, Kim KU, Kim YK, Uh ST. Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report. World J Clin Cases 2021; 9(24): 7205-7211 [PMID: 34540979 DOI: 10.12998/wjcc.v9.i24.7205]
URL: https://www.wjgnet.com/2307-8960/full/v9/i24/7205.htm
Number Citing Articles
1
Huohuan Tian, Linhui Yang, Wang Hou, Yu Wu, Yang Dai, Jiang Yu, Dan Liu. Case report: Identification of acute promyelocytic leukemia during osimertinib resistance followed by granulocyte colony-stimulating factor and pembrolizumabFrontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1032225
2
AntineoplasticsReactions Weekly 2021; 1879(1): 43 doi: 10.1007/s40278-021-04527-y
3
Libo Zhang, Meijuan Huang. Chronic myeloid leukemia during osimertinib treatment in a non-small cell lung cancer patient: A case reportHeliyon 2024; 10(17): e37040 doi: 10.1016/j.heliyon.2024.e37040